Cargando…

Systemic sarcoidosis induced by etanercept: first Brazilian case report

The antagonists of tumor necrosis factor alpha (TNF-α) are increasingly being used in the treatment of inflammatory and autoimmune diseases. Several adverse effects of these drugs have been reported, including the paradoxical development of sarcoidosis, especially with the use of etanercept. We pres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Unterstell, Natasha, Bressan, Aline Lopes, Serpa, Laura Araújo, Castro, Pérola Peres da Fonseca e, Gripp, Alexandre Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Dermatologia 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875991/ https://www.ncbi.nlm.nih.gov/pubmed/24346918 http://dx.doi.org/10.1590/abd1806-4841.20132588

Ejemplares similares

Bullous pemphigoid and neurological disease: statistics from a dermatology service()
por: Tarazona, Monica Jidid Mateus, et al.
Publicado: (2015)

Mononeuritis multiplex as the first presentation of refractory sarcoidosis responsive to etanercept
por: Marques, Inês Brás, et al.
Publicado: (2014)

Pulmonary Sarcoidosis following Etanercept Treatment
por: Bhamra, Kuljeet, et al.
Publicado: (2012)

Skin manifestations associated with systemic diseases – Part I()()
por: Sampaio, Ana Luisa, et al.
Publicado: (2021)

Sarcoidosis secondary to lymphocyte active immunotherapy treated with infliximab
por: de Souza, Gabriela Higino, et al.
Publicado: (2018)

Development of Propionibacterium acnes-associated Sarcoidosis During Etanercept Therapy
por: Isshiki, Takuma, et al.
Publicado: (2019)

Prognostic features of sarcoidosis course in a Brazilian cohort
por: Castro, Marina Dornfeld Cunha, et al.
Publicado: (2022)

Cutaneous and pulmonary manifestations of sarcoidosis triggered by coronavirus disease 2019 infection
por: Rodrigues, Felipe Tavares, et al.
Publicado: (2022)

Primary systemic amyloidosis, acquired cutis laxa and cutaneous mucinosis in a patient with multiple myeloma
por: Lavorato, Fernanda Guedes, et al.
Publicado: (2013)

Lichen sclerosus associated with localized scleroderma: dermoscopy contribution
por: Nóbrega, Monisa Martins, et al.
Publicado: (2016)

Lung Sarcoidosis in Etanercept Treated Rheumatoid Arthritis Patient: A Case Report and Review of the Literature
por: Thongpooswan, Supat, et al.
Publicado: (2014)

Pulmonary Sarcoidosis following Etanercept Treatment for Ankylosing Spondylitis: A Case Report and Review of the Literature
por: Majjad, A., et al.
Publicado: (2018)

Off-label use of rituximab in dermatology: pemphigus treatment
por: Bomm, Lislaine, et al.
Publicado: (2013)

Etanercept in erythema nodosum leprosum
por: Santos, Julia Rocha Silva, et al.
Publicado: (2017)

Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2023)

Etanercept biosimilars
por: Azevedo, Valderilio F., et al.
Publicado: (2014)

Sarcoidosis Presenting as Cranial Multinevritis
por: Xavier Pires, Sara, et al.
Publicado: (2021)

Treatment of LADA With Etanercept
por: Montes, Vince N., et al.
Publicado: (2012)

Etanercept-associated myelitis
por: Finke, Carsten, et al.
Publicado: (2015)

Etanercept-associated Nephropathy
por: Ammar, Awais, et al.
Publicado: (2019)

Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
por: Felis-Giemza, Anna, et al.
Publicado: (2019)

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Real-World Experience with Etanercept Therapy and the Switching Pattern among Korean Patients with Psoriasis after Withdrawal of Etanercept
por: Choi, Chong Won, et al.
Publicado: (2019)

Post COVID-19 vaccine adenopathy: first Brazilian report
por: Viana, Joshua Araújo, et al.
Publicado: (2021)

Intramedullary Cervical Sarcoidosis as the Initial Presentation of Systemic Sarcoidosis
por: Razdan, Rishi N., et al.
Publicado: (2016)

Developing of Granulomatosis with Polyangiitis during Etanercept Therapy
por: Ortiz-Sierra, María Clara, et al.
Publicado: (2014)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

GP2015: An Etanercept Biosimilar
por: Deeks, Emma D.
Publicado: (2017)

First Brazilian datathon in critical care
por: Serpa Neto, Ary, et al.
Publicado: (2018)

Defining prognosis in sarcoidosis
por: Lopes, Mariana Carneiro, et al.
Publicado: (2020)

Cultural adaptation of the mental health first aid guidelines for Brazilians with problem drinking: a Delphi expert consensus study
por: Ayoub, Ibrahim Ali, et al.
Publicado: (2022)

Elevated Aminotransaminases As the First Manifestation of Sarcoidosis
por: Nawfal, Georges, et al.
Publicado: (2009)

Etanercept-Associated Transient Bone Marrow Aplasia: A Review of the Literature and Pathogenetic Mechanisms
por: Kozak, Natasha, et al.
Publicado: (2014)

Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
por: Chadwick, Laura, et al.
Publicado: (2018)

Perispinal etanercept: Potential as an Alzheimer therapeutic
por: Griffin, W Sue T
Publicado: (2008)

The safety of etanercept for the treatment of plaque psoriasis
por: Papp, Kim A
Publicado: (2007)

Infertility improved by etanercept in ankylosing spondylitis
por: Rezvani, Aylin, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_0ou9snmn99kaib4u0omtfs5fir